...
首页> 外文期刊>Vascular and endovascular surgery >Single-center experience of caval thrombectomy in patients with renal cell carcinoma with tumor thrombus extension into the inferior vena cava.
【24h】

Single-center experience of caval thrombectomy in patients with renal cell carcinoma with tumor thrombus extension into the inferior vena cava.

机译:肾细胞癌伴有血栓延伸至下腔静脉的患者行腔内血栓切除术的单中心经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of this study is to describe a single-center experience of caval thrombectomy in patients with renal cell carcinoma (RCC) and tumor thrombus extension into the inferior vena cava (IVC). We retrospectively reviewed 23 patients undergoing radical nephrectomy with caval thrombectomy. Follow-up included an office visit and computed tomography scan. Statistical comparisons were made using 2-sample t tests. Patients' ages ranged from 32 to 83 years (mean, 62 years; 18 male, 5 female). Tumor size ranged from 3 to 21 cm (mean, 8.6 cm). Tumor thrombus staging was based on the Nevus classification: level I (2/23), II (6/23), III (13/26), IV (2/23). Tumor thrombi were removed by means of digital extraction (20), Fogarty embolectomy (2), or endarterectomy (1-caval wall invasion). Lateral venorrhaphy was used for IVC repair in all cases. Hepatic mobilization and suprahepatic clamping were necessary in 14 patients. Clamp times were significantly different between the suprahepatic (SH) and infrahepatic (IH) groups (15 vs 9.4 minutes, P < .012). Mean blood loss was also significantly different (3.2 L vs 2 L, P < .045). In the SH group, 2 patients developed postoperative atrial fibrillation and 2 patients died (respiratory failure; missed enterotomy). The IH group had no perioperative morbidity or mortality. Median followup was 15 months (range, 1-54 months). Follow-up imaging was available for 19/23 patients. Ninety-five percent of patients had a patent IVC (18). One SH patient developed an IVC stenosis/thrombosis 12 months postoperatively with successful thrombolysis and stenting. There was a 16% (3/19) recurrence rate in follow-up, with all patients demonstrating renal vascular invasion and high Fuhrman grade upon final pathologic evaluation. Caval thrombectomy can be performed safely during radical nephrectomy for RCC with tumor thrombus extension. The need for suprahepatic clamping is associated with longer clamp times, increased blood loss, and increased morbidity and mortality. Lateral venorrhaphy withprimary repair avoids complicated caval reconstructions and results in high patency rates, despite a not insignificant recurrence rate.
机译:这项研究的目的是描述肾细胞癌(RCC)和肿瘤血栓延伸至下腔静脉(IVC)的患者进行腔内血栓切除术的单中心经验。我们回顾性地回顾了23例行根治性肾切除术并行腔内血栓切除术的患者。随访包括上门拜访和计算机断层扫描。使用2样本t检验进行统计比较。患者年龄为32至83岁(平均62岁;男性18岁,女性5岁)。肿瘤大小为3至21厘米(平均8.6厘米)。肿瘤血栓分期基于痣分类:I级(2/23),II级(6/23),III级(13/26),IV级(2/23)。通过数字提取(20),Fogarty栓塞切除术(2)或动脉内膜切除术(1腔壁浸润)除去肿瘤血栓。在所有情况下,均采用外侧静脉腔修补术。 14例患者需要肝动员和肝上夹持。肝上(SH)组和肝下(IH)组的钳夹时间显着不同(15 vs 9.4分钟,P <.012)。平均失血量也有显着差异(3.2 L vs 2 L,P <.045)。在SH组中,有2例患者发生了术后房颤,有2例死亡(呼吸衰竭;未进行肠切开术)。 IH组无围手术期发病率或死亡率。中位随访时间为15个月(范围:1-54个月)。 19/23例患者可进行随访成像。 95%的患者拥有IVC专利(18)。一名SH患者在术后12个月发展为IVC狭窄/血栓形成,并成功溶栓并置入支架。随访中复发率为16%(3/19),所有患者在最终病理评估后均显示出肾血管侵犯和Fuhrman评分高。对于具有肿瘤血栓扩展的RCC,可以在根治性肾切除术中安全地进行caval血栓切除术。肝上夹持的需要与更长的夹持时间,增加的失血量以及增加的发病率和死亡率有关。尽管复发率并不低,但进行初次修复的外侧静脉腔避免了复杂的腔体重建,并导致高通畅率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号